No Record Found
No Record Found
Sector
PharmaceuticalsOpen
₹2,506Prev. Close
₹2,506Turnover(Lac.)
₹1,15,126.72Day's High
₹2,525.5Day's Low
₹2,38052 Week's High
₹2,525.552 Week's Low
₹1,648.9Book Value
₹251.48Face Value
₹1Mkt Cap (₹ Cr.)
38,676.99P/E
56.68EPS
42.56Divi. Yield
0.9125 May 2026
12:00 AM
AGM
Announcement Date: 25 May, 2026
5 May 2026
12:00 AM
Board Meeting
Agenda : Audited Result
11 May 2026
12:00 AM
Dividend
Dividend Amount: 9.3
Record Date: 29 May, 2026
27 Mar 2026
12:00 AM
EGM
The transaction involves around 38.75 lakh shares, priced at ₹1,600 each, being offloaded by JB Chemicals employees who recently converted their stock options.
The inspection was conducted from March 10 to March 13 of 2025 at Plot No. 5, GIDC, Panoli, Gujarat facility.
EBITDA at the operating level jumped 14.1% to ₹254.5 crore from ₹223.1 crore in the same quarter last year.
| Y/e 31 Mar( In .Cr) | Mar-2026 | Mar-2025 | Mar-2024 | Mar-2023 |
|---|---|---|---|---|
Equity Capital | 16.06 | 15.57 | 15.52 | 15.51 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 4,021.65 | 3,361.63 | 2,870.74 | 2,426.98 |
Net Worth | 4,037.71 | 3,377.2 | 2,886.26 | 2,442.49 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 2,189.87 | 1,891.99 | 1,640.74 | 1,250.13 |
yoy growth (%) | 15.74 | 15.31 | 31.24 | 6.42 |
Raw materials | -743.69 | -625.75 | -569.13 | -479.67 |
As % of sales | 33.96 | 33.07 | 34.68 | 38.36 |
Employee costs | -399.06 | -305.97 | -293.78 | -217.3 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 471.29 | 593.7 | 349.56 | 179.04 |
Depreciation | -71.28 | -67.35 | -65.09 | -55.94 |
Tax paid | -110.29 | -146.62 | -71.41 | -51.04 |
Working capital | 298.14 | 110.36 | 28.72 | 67.62 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 15.74 | 15.31 | 31.24 | 6.42 |
Op profit growth | -7.84 | 49.09 | 85.51 | -10.11 |
EBIT growth | -20.74 | 70.46 | 93.19 | -17.73 |
Net profit growth | -19.25 | 66.73 | 109.48 | -25.99 |
| Particulars (Rupees in Crores.) | Mar-2026 | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|---|
Gross Sales | 4,147.79 | 3,917.99 | 3,484.18 | 3,149.28 | 2,424.24 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 4,147.79 | 3,917.99 | 3,484.18 | 3,149.28 | 2,424.24 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 60.15 | 38.32 | 37.27 | 9.94 | 39.23 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,758.8 | 132.68 | 4,22,426.91 | 1,115.14 | 0.91 | 5,641.31 | 93.23 |
Divis Laboratories Ltd DIVISLAB | 9,144.5 | 80.11 | 2,39,982.27 | 891 | 0.33 | 2,974 | 629.49 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 4,558.9 | 85.42 | 1,75,195.53 | 492 | 0.73 | 4,073 | 222.76 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,123 | 31.22 | 1,13,790.25 | 339.6 | 0.09 | 2,723.5 | 237.3 |
Laurus Labs Ltd LAURUSLABS | 2,060.1 | 125.08 | 1,09,143.07 | 289.96 | 0.1 | 1,757.16 | 97.2 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Independent Directo
Arun Duggal
Independent Non Exe. Director
Sumit Bose
Independent Non Exe. Director
Ashwani Puri
Independent Non Exe. Director
Richa Arora
Executive Director & MD
Aman Mehta
Non-Exec & Non-Independent Dir
Amal Satyawan Kelshikar
Non-Exec & Non-Independent Dir
Hasmukh Patel
Non-Exec & Non-Independent Dir
Sudhir Menon
VP - Secretarial / CS / CO
SANDEEP PHADNIS
302 ISCON Mall Star India,
Bazar Bldg Opp Jodhpur BRTS Sa,
Gujarat - 380015
Tel: 91-022-2482 2222/2493 0918
Website: http://www.jbpharma.com
Email: investorelations@jbpharma.com; secretarial@jbpharm
Plot No B-5 MIDC,
Part B Cross Lane, Marol Andheri(E),
Mumbai-400093
Tel: 91-22-6671 2151
Website: www.dfssl.com
Email: marketing@dfssl.com/investorsqry@dfssl.com
Summary
J B Chemicals & Pharmaceuticals Limited (JBC) was originally promoted and incorporated in Maharashtra by J B Mody as J B Mody Chemicals & Pharmaceuticals on December 18, 1976. The Company engage in ma...
Read More
Reports by J B Chemicals & Pharmaceuticals Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
